Skip to main content
Equibles
NHTC logo

NHTC · Natural Health Trends Corp · Metrics

Track NHTC — free

Use NHTC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NHTC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.82 -0.03 (-3.66%)
Rebalance outlook locked
Market Cap
$7.27M
Shares
8.58M
Volume · Oct 22 39.31K Avg daily vol (3M) 60.63K

NHTC metrics

91 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.84
Market cap
$7.27M

Price action

20 metrics
Price change (1W)
-12.5%
Price change (30D)
-24.0%
Price change (3M)
-53.6%
Price change (6M)
-71.5%
Price change (YTD)
-72.9%
Price change (1Y)
-81.2%
Trailing year
Price change (5Y)
-88.4%
52-week high
$4.45
52-week low
$0.84
Change from 52-week high
-81.2%
Change from 52-week low
+0.0%
Annualized volatility
80.2%
Annualized volatility (3M)
67.8%
Beta
0.9
RSI (14D)
25.3
Price vs SMA 50
-36.7%
Price vs SMA 200
-65.0%
Avg volume (3M)
60,630
Relative volume
0.7
Average dollar volume
$78,898

Company

3 metrics
Sector
Consumer Cyclical
Industry
Internet Retail
Shares outstanding
8.58M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 496.0%
P / book
0.5
reciprocal yield 209.2%
FCF yield
-48.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-22.4%

Historical valuation

8 metrics
P / E historical average (3Y)
137.5×
reciprocal yield 0.7%
P / E historical average (5Y)
118.3×
reciprocal yield 0.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
47.2%
Trailing 12 months
Payout ratio
—
Shareholder yield
87.0%
Dividend / share (TTM)
$0.40
Dividend growth YoY
-50.0%
Dividend growth streak
0
Last ex-dividend
2026-05-12

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
74.1%
Operating margin
-6.2%
Trailing 12 months
Net margin
-4.5%
Gross profit (TTM)
$26.72M
Operating profit (TTM)
−$2.25M
Net income (TTM)
−$1.62M
Trailing 12 months
Diluted EPS (TTM)
$-0.16
FCF margin
-9.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.47
Gross profit per diluted share (TTM)
$2.57
Operating profit per diluted share (TTM)
$-0.22
EBITDA per diluted share (TTM)
$-0.21
Net income per diluted share (TTM)
$-0.16
Operating cash flow per diluted share (TTM)
$-0.31
Free cash flow per diluted share (TTM)
$-0.36
Capital expenditures per diluted share (TTM)
$0.05
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.01
Book value per share
$8.69

Growth

11 metrics
Revenue growth YoY
-22.5%
Year over year
Net income growth YoY
-3,106.7%
Revenue (TTM)
$36.03M
Trailing 12 months
EPS growth YoY
-260.0%
Shares change YoY
-25.4%
Year over year · fewer shares
Revenue CAGR (3Y)
-6.8%
Revenue CAGR (5Y)
-8.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-10.7%
Return on assets
-5.6%
Debt / equity
—
Current ratio
2.0
EBITDA (TTM)
−$2.16M
Free cash flow (TTM)
−$3.50M
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$18.62M
Latest balance sheet
Cash & equivalents
$9.50M
Total assets
$29.21M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$3.01M
Capital expenditures (TTM)
$488,000
R&D (TTM)
—
SG&A (TTM)
$14.20M
Stock compensation (TTM)
$64,000
R&D / revenue
—
Stock compensation / revenue
0.2%

Ownership (13F)

9 metrics
13F filers
23
13F filer change QoQ
-1
Institutional ownership
12.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
7.9%
Private-fund adviser ownership
7.3%
Active holders' share change QoQ
+0.3%
Holder tenure
18.8
Price vs estimated holder cost
-57.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 912061 CUSIP 63888P406 13F (30d) 1 filings 1 filers Visit website Investor relations